Nutrition and Dialysis
Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters,☆☆

https://doi.org/10.1053/ajkd.2001.20754Get rights and content

Abstract

We analyzed the prognostic importance of nutritional markers and mortality data in 537 hemodialysis (HD) and 422 peritoneal dialysis (PD) patients followed for up to 12 years. Patients on HD had a 44% lower risk of mortality than did those treated with PD (P < 0.0001). The difference in mortality between the modalities was even more striking among diabetics but less striking among younger patients. Over a 12-year period, survival of dialysis patients with lower enrollment levels of albumin, creatinine, and parathyroid hormone (PTH) were significantly lower. In multivariate Cox’s proportional hazards models, serum prealbumin and enrollment PTH level of <65 pg/mL were independent predictors of mortality both in HD and PD patients. In conclusion, HD patients had higher cumulative survival than PD patients over a 12-year period. Nutritional markers at enrollment continue to be strong predictors of mortality for up to 12 years.

Section snippets

Patients

Five hundred thirty-seven HD patients and 422 PD patients treated at the Long Island College Hospital’s outpatient dialysis facilities were enrolled in this study from 1987 to 1999. For the prealbumin study, 126 HD and 116 PD patients were enrolled beginning June 1991. The patients were followed up to January 1, 2000. Follow-up was censored on transplantation, transfer of dialysis modality, or transfer to another dialysis center. On enrollment, the following demographic and clinical data were

Patient characteristics

Table 1 describes the demographic, clinical, and biochemical characteristics of HD and PD patients. The causes of renal failure were similar in the two dialysis modalities except for a higher proportion of human immunodeficiency virus (HIV) infection (7.9% v 1.7%) in PD patients.

Discussion

We have shown that HD patients had 44% lower mortality risk than those patients treated with PD. Our results are in agreement with those of Lowrie et al1 and Bloembergen et al.2 The mortality risk for diabetic PD patients was more than twice that of diabetic HD patients (P < 0.0001) which is in agreement with findings by Held et al.10 Our study is unique in that we have followed a large number of patients in a single center for up to 12 years. The most likely explanation for excess mortality in

Cited by (77)

  • Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis

    2016, Kidney Research and Clinical Practice
    Citation Excerpt :

    In our study, the AUC value of prealbumin for mortality was the largest among the various nutritional parameters, whereas serum albumin did not reach a clinically significant relationship with mortality by AUC and multivariate analyses. On the contrary, Avram et al [7] reported that serum albumin is an independent predictor of mortality in patients on PD (relative risk, 0.52) in the univariate regression model, and higher enrollment level of serum albumin is associated with better survival [29]. Moreover, a low serum albumin level had been used as an indicator of malnutrition in dialysis patients [30].

  • Nutrition and the Kidney: Recommendations for Peritoneal Dialysis

    2013, Advances in Chronic Kidney Disease
    Citation Excerpt :

    Because of its shorter half-life in patients without CKD, serum transthyretin (prealbumin) has been suggested to be a better nutritional marker compared with albumin. In a large cohort study, a reduced prealbumin concentration was shown to correlate to albumin and other laboratory surrogate markers and to be associated with an increased risk of mortality.18 However, large studies comparing prealbumin concentration to other nutritional measures in PD are lacking.

View all citing articles on Scopus

Supported by National Kidney Foundation of New York/New Jersey and Nephrology Foundation of Brooklyn.

☆☆

Address reprint requests to Morrell M. Avram, MD, FACP, Avram Division of Nephrology, Long Island College Hospital, 339 Hicks Street, Brooklyn, NY 11201. E-mail: [email protected]

View full text